Emergent BioSolutions Inc
(NYSE:EBS)
$
12.01
0.24 (2.04%)
Market Cap: 650.75 Mil
Enterprise Value: 1.43 Bil
PE Ratio: 0
PB Ratio: 1.65
GF Score: 68/100 Emergent BioSolutions Inc at Cowen Healthcare Conference (Virtual) Transcript
Mar 01, 2021 / 05:20PM GMT
Release Date Price:
$102.2
(+6.46%)
Boris Peaker
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
Well, welcome, everybody, and thank you for joining our discussion with Emergent BioSolutions. Let's just dive right in since we only have 0.5 hour here.
Questions & Answers
Boris Peaker
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
There's been a lot of interest in your CDMO business certainly over the last year. And so maybe start with Bob. Can you talk a little bit about the history of the CDMO business, how it came to be the folks of organization? How should investors be thinking about it? Maybe talk a little about some of the backlog and some of the new metrics you've provided for investors to better understand the business. And how should we be thinking about it several years in the future?
Robert G. Kramer
Emergent BioSolutions Inc. - CEO, President & Executive Director
Sure. So first of all, Boris, thanks for the opportunity to participate in the conference. Good to see
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot